AstriVax
AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline
2
Funding Rounds
$30.0m
Money raised
Overview
AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline
- Website:
- Business model: B2B
- Headquarters: Leuven
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company AstriVax has raised a total of $30m in funding over 2 rounds.
Key Insights:
- AstriVax August 2022 Seed Funding Round: $30m
AstriVax August 2022 Seed Funding Round
$30m
Industries
AstriVax is active in the following industries: